- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
ADAC Laboratories lays off 10% of staff, despite gains
Company sees hazy future for gamma camera salesThe month of April was a study in contrasts for gamma camera vendorADAC Laboratories. While the Mountain View, CA-based company reportedsharply higher revenues and earnings for the quarter, it was
Company sees hazy future for gamma camera sales
The month of April was a study in contrasts for gamma camera vendorADAC Laboratories. While the Mountain View, CA-based company reportedsharply higher revenues and earnings for the quarter, it was forcedto let go 10% of its work force due to uncertainty about the futureof nuclear medicine equipment sales.
ADAC's financial numbers surged strongly last year, based largelyon the performance of Genesys Vertex, its variable-angle dual-headgamma camera. ADAC quickly built up a backlog of the units followingthe camera's release.
The market for gamma cameras took a dive in the fourth quarterof 1994, however, and by all indications is still mired in a salesslump. ADAC announced in March that it expected its second-quarterresults to be below expectations (SCAN 4/6/94).
Despite the slump, ADAC's numbers are still impressive. Thecompany recorded $47.3 million in revenue for the second quarter(end-April), a 26% increase over the $37.6 million reported inthe second quarter of 1993. Net income climbed to $5.5 million,compared to $4.4 million in the second quarter a year ago -- anincrease of 25%.
Bookings for the quarter increased only 3% compared to lastyear, lower than what is required to maintain ADAC's revenue levelswithout depleting its backlog and reducing production efficiency,according to chairman and co-CEO Stanley D. Czerwinski.
"Because of this (low bookings level) and the currentview of the state of our core market, revenue and earnings inthe near future are expected to be lower than this past quarter,"Czerwinski said.
To prepare the company for an extended slowdown, ADAC reducedits work force by 10% in April. The reduction was made to "alignthe company with the new emphasis on lower costs resulting fromhealth-care reform," according to the company.
ADAC also noted that there has been no resolution regardinglitigation with competitor Elscint. Elscint filed a patent infringementsuit against ADAC last year, and has asked for a preliminary injunctionbarring ADAC from manufacturing gamma cameras until the suit isresolved (SCAN 3/2/94). ADAC filed a counter suit against Elscintin February, charging the Israeli vendor with infringing on nuclearmedicine patents ADAC acquired from Philips Medical Systems.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
